These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6296154)

  • 1. Estimation of the bacterial content of pertussis vaccines by dry weight and nitrogen determinations of bacterial mass.
    Csizér Z; Niedermayer N; Szammet A; Zsidai J
    J Biol Stand; 1982 Oct; 10(4):269-72. PubMed ID: 6296154
    [No Abstract]   [Full Text] [Related]  

  • 2. Estimation of bacterial mass of pertussis vaccine by opacity and dry weight determinations.
    Csizér Z; Szammet A; Niedermayer N; Zsidai F; Auber E; Foó I
    J Biol Stand; 1977; 5(4):289-95. PubMed ID: 200630
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental relation between histamine-sensitizing factor and the protective antigen of Bordetella pertussis].
    Jiménez Paredes J; Ruiz Puente J; González Pacheco M
    Salud Publica Mex; 1981; 23(6):621-9. PubMed ID: 6278660
    [No Abstract]   [Full Text] [Related]  

  • 4. [Intracellular structural arrangement of pertussis toxins (factors) and suggestions on production of safe and effective vaccines].
    Kuwajima Y
    Kansenshogaku Zasshi; 1978 Feb; 52(2):56-9. PubMed ID: 213507
    [No Abstract]   [Full Text] [Related]  

  • 5. The purification and characterization of an acellular pertussis vaccine.
    Chazono M; Yoshida I; Konobe T; Fukai K
    J Biol Stand; 1988 Apr; 16(2):83-9. PubMed ID: 2897370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attempts at analysis of toxicity of pertussis vaccine. I. Body weight-decreasing toxicity in mice.
    Kurokawa M; Ishida S; Iwasa S; Asakawa S; Kuratsuka K
    Jpn J Med Sci Biol; 1968 Apr; 21(2):137-53. PubMed ID: 4299576
    [No Abstract]   [Full Text] [Related]  

  • 7. Key points for the development of mouse immunogenicity test as potency assay for acellular pertussis vaccines.
    André M; Poirier B; Bornstein N; Marmonier D; El Zaouk A; Fuchs F
    Biologicals; 2000 Dec; 28(4):217-25. PubMed ID: 11237357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of purified components of Bordetella pertussis in the weight gain test for the toxicity testing of pertussis vaccines.
    Redhead K; Seagroatt V
    J Biol Stand; 1986 Jan; 14(1):57-65. PubMed ID: 2870067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newer pertussis vaccines on horizon.
    González ER
    JAMA; 1982 Jul; 248(1):22-3. PubMed ID: 6283186
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of a nitric oxide induction assay as a potential replacement for the intracerebral mouse protection test for potency assay of pertussis whole cell vaccines.
    Canthaboo C; Xing D; Corbel M
    Dev Biol Stand; 1999; 101():95-103. PubMed ID: 10566781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single radial immunodiffusion as a method for the assay of the acellular pertussis vaccine components, pertussis toxoid, filamentous haemagglutinin and pertactin.
    Xing DK; Canthaboo C; Corbel MJ; Schild GC
    Biologicals; 1998 Sep; 26(3):217-24. PubMed ID: 10208723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detoxification of pertussis vaccines.
    Ashworth LA; Robinson A
    Lancet; 1987 Sep; 2(8559):632. PubMed ID: 2887923
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of Bordetella pertussis preserved in liquid nitrogen as a challenge suspension in the Kendrick mouse protection test.
    Novotny P; Brookes JE
    J Biol Stand; 1975; 3(1):11-29. PubMed ID: 165201
    [No Abstract]   [Full Text] [Related]  

  • 14. Bordetella pertussis serotypes in Canada.
    Toma S; Lo H; Magus M
    Can Med Assoc J; 1978 Oct; 119(7):722-4. PubMed ID: 213182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Toxicity of Bordetella pertussis suspensions associated with the preparation of pertussis vaccine].
    Raĭkher LI; Kalinina ES; Shafran MI; Khazina EKh; Aĭnbinder ZTs
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Mar; (3):15-7. PubMed ID: 6303021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of a protein with hypoglycaemic effect from Bordetella pertussis cell extracts.
    Kishore M; Baxi AJ; Ramakrishnan P
    Indian J Med Res; 1986 Feb; 83():139-47. PubMed ID: 2872158
    [No Abstract]   [Full Text] [Related]  

  • 17. Lipopolysaccharides in a traditional pertussis vaccine.
    Ibsen P; Møller S; Heron I
    J Biol Stand; 1988 Oct; 16(4):299-309. PubMed ID: 2904442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International symposium on pertussis evaluation and research on acellular pertussis vaccines. National Institute of Health in Tokyo and International Association of Biological Standardization. 14-15 September 1990 at Shizuoka, Japan.
    Biologicals; 1991 Apr; 19(2):145-9. PubMed ID: 1888495
    [No Abstract]   [Full Text] [Related]  

  • 19. Pertussis vaccine--fact and fiction.
    Cameron J; Stainer DW
    Acta Microbiol Acad Sci Hung; 1977; 24(3):195-205. PubMed ID: 203169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pertussis vaccine.
    Robinson A; Ashworth LA; Irons L
    Lancet; 1982 Jul; 2(8289):108. PubMed ID: 6123801
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.